Rabia Khan

Founder, StealthMode Startup

Rabia has a background in immuno-genetics and she is focussed on bridging the worlds of science, business and technology in the areas of medicine, healthcare, network biology and genomics. Most recently, she was Managing Director for the Discovery Sciences division at Sensyne Health, a publicly listed company with a unique partnership model with the National Health Service (NHS). At Sensyne Health, she established the scientific strategy and built the data science and discovery teams. She had a key role in many partnerships with pharms. Prior to joining Sensyne Health, Rabia held senior roles at BenevolentAI and Meta. At Meta, she was pivotal in the partnership with the Intelligence Advanced Research Projects Activity (IARPA). At BenevolentAI, she led the Age-Related Macular Degeneration and Glioblastoma drug discovery programs and served as the interface between the technical and biological teams alongside Prof. Jackie Hunter. Rabia regularly presents on embracing the intersection of healthcare and technology to advance better patient outcomes and advocates the importance of STEM in industry and education. Currently, she is Founder and CEO of Ladder Therapeutics, a foundation stage biotech, a YCombinator company.

See the program of this speaker